SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-23-000036
Filing Date
2023-08-10
Accepted
2023-08-10 16:06:29
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20230630x10q.htm   iXBRL 10-Q 1099787
2 EX-31.1 alt-20230630xex31d1.htm EX-31.1 11932
3 EX-31.2 alt-20230630xex31d2.htm EX-31.2 11775
4 EX-32.1 alt-20230630xex32d1.htm EX-32.1 6752
5 EX-32.2 alt-20230630xex32d2.htm EX-32.2 6882
6 GRAPHIC alt-20230630x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-23-000036.txt   4610221

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20230630.xsd EX-101.SCH 31583
8 EX-101.CAL alt-20230630_cal.xml EX-101.CAL 39356
9 EX-101.DEF alt-20230630_def.xml EX-101.DEF 110898
10 EX-101.LAB alt-20230630_lab.xml EX-101.LAB 315384
11 EX-101.PRE alt-20230630_pre.xml EX-101.PRE 207548
49 EXTRACTED XBRL INSTANCE DOCUMENT alt-20230630x10q_htm.xml XML 696939
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 231159321
SIC: 2834 Pharmaceutical Preparations